Answers are grounded in this paper and cite their sources.
Illustration of succinate levels in multiple myeloma patients reveals distinct therapy outcomes, implying microbiota may influence treatment results.
Supplementary Figure S20 illustrates succinate levels on the day of apheresis in multiple myeloma (MM) patients from the first cohort. This figure presents stool samples and serum samples, both stratified by therapy outcome.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: